Literature DB >> 7524207

Gal alpha(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies.

H A Vaughan1, B E Loveland, M S Sandrin.   

Abstract

Hyperacute rejection, mediated by natural antibody, is the major barrier to xenotransplantation. The studies reported herein were aimed at evaluating antibody-mediated cytotoxicity and the role of the Gal alpha(1,3)Gal epitope, which we had previously demonstrated was the major epitope of pig cells detected by naturally occurring human antibodies. Also, we had shown that this epitope could be induced in non-expressing cells by the transfection of a cDNA clone encoding alpha(1,3)galactosyl transferase, the enzyme that produces this epitope. The importance of the Gal alpha(1,3)Gal epitope was supported by (1) sugar inhibition studies; (2) complete absorption of cytotoxic antibodies by melibiose-sepharose columns; and (3) the ability of normal human serum to lyse COS cells after transfection with a cDNA clone encoding alpha(1,3)galactosyl transferase. These findings strongly suggest that the majority of cytotoxic human antibodies that would recognize a xenogeneic graft are directed to the Gal alpha(1,3)Gal epitope.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524207     DOI: 10.1097/00007890-199410270-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

2.  Interaction of baboon anti-alpha-galactosyl antibody with pig tissues.

Authors:  S Maruyama; E Cantu; C DeMartino; C Y Wang; J Chen; F Al-Mohanna; S M Nakeeb; V D'Agati; B Pernis; U Galili; G Godman; D M Stern; G Andres
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  Extracellular matrix-based biomaterial scaffolds and the host response.

Authors:  Joseph M Aamodt; David W Grainger
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

4.  Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.

Authors:  N Osman; I F McKenzie; K Ostenried; Y A Ioannou; R J Desnick; M S Sandrin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Induction of cytolytic anti-Gal antibodies in alpha-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria.

Authors:  Karla J Posekany; H Keith Pittman; John F Bradfield; Carl E Haisch; Kathryn M Verbanac
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Specific inhibition of an alpha-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues.

Authors:  V Kolb; F Amann; R R Schmidt; M Duszenko
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

7.  Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.

Authors:  R M Welsh; C L O'Donnell; D J Reed; R P Rother
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.

Authors:  R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  Direct Injection of CRISPR/Cas9-Related mRNA into Cytoplasm of Parthenogenetically Activated Porcine Oocytes Causes Frequent Mosaicism for Indel Mutations.

Authors:  Masahiro Sato; Miyu Koriyama; Satoshi Watanabe; Masato Ohtsuka; Takayuki Sakurai; Emi Inada; Issei Saitoh; Shingo Nakamura; Kazuchika Miyoshi
Journal:  Int J Mol Sci       Date:  2015-08-03       Impact factor: 5.923

10.  Targeted toxin-based selectable drug-free enrichment of Mammalian cells with high transgene expression.

Authors:  Masahiro Sato; Eri Akasaka; Issei Saitoh; Masato Ohtsuka; Shingo Nakamura; Takayuki Sakurai; Satoshi Watanabe
Journal:  Biology (Basel)       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.